Comportements addictifs et maladie de Parkinson

Revue Neurologique

Volumn 168, Issue 8-9, 2012, Pages 624-633

  Witjas, T ^a   Eusebio, A ^a   Fluchere F ^a   Azulay, J P ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Addiction; Dopamine dysregulation syndrome; Dopamine replacement therapy; Impulse control disorders; Parkinson's disease; Punding

Indexed keywords

AMANTADINE; ANTIANDROGEN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; APOMORPHINE; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; TOPIRAMATE; ZONISAMIDE;

ADDICTION; ADJUVANT THERAPY; ANXIETY; BEHAVIOR DISORDER; BINGE EATING DISORDER; BRAIN DEPTH STIMULATION; CIGARETTE SMOKING; COMPULSION; COMPULSIVE BUYING; DEPRESSION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOPAMINE DYSREGULATION SYNDROME; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG TOLERANCE; DRUG USE; DRUG WITHDRAWAL; EATING DISORDER; FAMILY HISTORY; HOARDING; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; INSOMNIA; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROSURGERY; NUCLEUS ACCUMBENS; ONSET AGE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PATHOPHYSIOLOGY; PATIENT COUNSELING; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PUNDING; QUESTIONNAIRE; RATING SCALE; RESTLESS LEGS SYNDROME; REVIEW; REWARD; RISK FACTOR; SCREENING TEST; SENSITIZATION; SEXUAL BEHAVIOR; SHY DRAGER SYNDROME; STEREOTYPY; SUBSTANCE ABUSE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; VENTRAL TEGMENTUM; BIOLOGICAL MODEL; BRAIN; CHEMICALLY INDUCED DISORDER; DRUG EFFECT;

BEHAVIOR, ADDICTIVE; BRAIN; COMPULSIVE BEHAVIOR; DOPAMINE; HUMANS; IMPULSE CONTROL DISORDERS; MODELS, BIOLOGICAL; PARKINSON DISEASE; REWARD;

EID: 84866365892     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2012.06.014     Document Type: Review

References (96)

1. D. Aarsland, G. Alves, and J.P. Larsen Disorders of motivation, sexual conduct, and sleep in Parkinson's disease Adv Neurol 96 2005 56 64
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV-TR). Washington, DC: American Psychiatric Publishing; 2000.
3. C. Ardouin, V. Voon, Y. Worbe, C. Abouazar, V. Czernecki, and H. Hossein Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation Mov Disord 21 11 2006 1941 1946 (Pubitemid 44848942)
4. C. Ardouin, I. Chereau, P.M. llorca, E. Lhommée, F. Durif, and P. Pollak Assessment of hyper and hypodopaminergic behaviours in Parkinson's disease Rev Neurol (Paris) 165 2009 845 856
5. M. Avanzi, M. Baratti, S. Cabrini, E. Uber, G. Brighetti, and F. Bonfà Prevalence of pathological gambling in patients with Parkinson's disease Mov Disord 21 12 2006 2068 2072 (Pubitemid 46140413)
6. M. Avanzi, M. Baratti, S. Cabrini, E. Uber, G. Brighetti, and F. Bonfà The thrill of reckless driving in patients with Parkinson's disease: an additional behavioural phenomenon in dopamine dysregulation syndrome? Parkinsonism Relat Disord 14 3 2008 257 258 (Pubitemid 351458416)
7. J.P. Azulay, T. Witjas, S. Cantiniaux, J. Régis, and J.C. Péragut Dopaminergic dysregulation syndrome in Parkinson's disease: a prospective study in patients treated with deep brain stimulation Neurology P04 2008 24
8. F. Bandini, A. Primavera, M. Pizzorno, and L. Cocito Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease Parkinsonism Relat Disord 13 6 2007 369 371 (Pubitemid 47212785)
9. C. Baunez, C. Dias, M. Cador, and M. Amalric The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards Nat Neurosci 8 4 2005 484 489 (Pubitemid 41007566)
10. P.E. Bermejo Topiramate in managing impulse control disorders in Parkinson's disease Parkinsonism Relat Disord 14 5 2008 448 449
11. P.E. Bermejo, C. Ruiz-Huete, and B. Anciones Zonisamide in managing impulse control disorders in Parkinson's disease J Neurol 257 10 2010 1682 1685
12. A. Bonci, and V. Singh Dopamine dysregulation syndrome in Parkinson's disease patients: from reward to penalty Ann Neurol 59 5 2006 733 734 (Pubitemid 43673149)
13. C. Bonvin, J. Horvath, B. Christe, T. Landis, and P.R. Burkhard Compulsive singing: another aspect of punding in Parkinson's disease Ann Neurol 62 5 2007 525 528 (Pubitemid 350308778)
14. L.L. Borek, and J.H. Friedman Levodopa addiction in idiopathic Parkinson disease Neurology 65 9 2005 150
15. J.A. Brewer, and M.N. Potenza The neurobiology and genetics of impulse control disorders: relationships to drug addictions Biochem Pharmacol 75 2008 63 75 (Pubitemid 350235392)
16. R. Cools Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease Neurosci Biobehav Rev 30 1 2006 1 23 (Pubitemid 41779404)
17. M.L. Dodd, K.J. Klos, J.H. Bower, Y.E. Geda, K.A. Josephs, and J.E. Ahlskog Pathological gambling caused by drugs used to treat Parkinson disease Arch Neurol 62 9 2005 1377 1381 (Pubitemid 41352054)
18. D. Drapier, S. Drapier, P. Sauleau, P. Derkinderen, P. Damier, and H. Allain Pathological gambling secondary to dopaminergic therapy in Parkinson's disease Psychiatry Res 144 2-3 2006 241 244 (Pubitemid 44666181)
19. E. Driver-Dunckley, J. Samanta, and M. Stacy Pathological gambling associated with dopamine agonist therapy in Parkinson's disease Neurology 61 3 2003 422 423 (Pubitemid 36975988)
20. E.D. Driver-Dunckley, B.N. Noble, J.G. Hentz, V.G. Evidente, J.N. Caviness, and J. Parish Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome Clin Neuropharmacol 5 2007 249 255 (Pubitemid 47511504)
21. Eusebio A, Witjas T, Cohen J, Fluchère F, Jouve E, Régis J, et al. Subthalamic nucleus stimulation as treatment for dopamine addiction in Parkinson's disease: a prospective study of 110 patients (submitted).
22. A.H. Evans, and H. Butzkueven Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis Mov Disord 22 4 2007 590 591 (Pubitemid 46608168)
23. A.H. Evans, and A.J. Lees Dopamine dysregulation syndrome in Parkinson's disease Curr Opin Neurol 17 4 2004 393 398 (Pubitemid 39071414)
24. A.H. Evans, R. Katzenschlager, D. Paviour, J.D. O'Sullivan, S. Appel, and A.D. Lawrence Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome Mov Disord 4 2004 397 405 (Pubitemid 38559642)
25. A.H. Evans, A.D. Lawrence, J. Potts, S. Appel, and A.J. Lees Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease Neurology 65 2005 1570 1574 (Pubitemid 41689470)
26. A.H. Evans, N. Pavese, A.D. Lawrence, Y.F. Tai, S. Appel, and M. Doder Compulsive drug use linked to sensitized ventral striatal dopamine transmission Ann Neurol 5 2006 852 858 (Pubitemid 43673163)
27. A.H. Evans, A.D. Lawrence, S.A. Cresswell, R. Katzenschlager, and A.J. Lees Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward Mov Disord 25 7 2010 867 876
28. A. Fasano, A.E. Elia, F. Soleti, A. Guidubaldi, and A.R. Bentivoglio Punding and computer addiction in Parkinson's disease Mov Disord 21 8 2006 1217 1218 (Pubitemid 44336611)
29. H.H. Fernandez, and J.H. Friedman Punding on L-dopa Mov Disord 14 5 1999 836 838
30. J.M. Ferrara, and M. Stacy Impulse-control disorders in Parkinson's disease CNS Spectr 13 8 2008 690 698
31. C.D. Fiorillo, P.N. Tobler, and W. Schultz Discrete coding of reward probability and uncertainty by dopamine neurons Science 299 5614 2003 1898 1902 (Pubitemid 36356659)
32. J. Friedman Punding on levodopa Biol Psychiatry 36 1994 350 351 (Pubitemid 124009226)
33. D.A. Gallagher, S.S. O'Sullivan, A.H. Evans, A.J. Lees, and A. Schrag Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series Mov Disord 22 12 2007 1757 1763 (Pubitemid 47597599)
34. W.R. Galpern, and M. Stacy Management of impulse control disorders in Parkinson's disease Curr Treat Options Neurol 9 3 2007 189 197 (Pubitemid 46736341)
35. G. Giovannoni, J.D. O'Sullivan, K. Turner, A.J. Manson, and A.J. Lees Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies J Neurol Neurosurg Psychiatry 68 4 2000 423 428 (Pubitemid 30248740)
36. A.M. Graybiel, J.J. Canales, and C. Capper-Loup Levodopa-induced dyskinesias and dopamine-dependent stereotypes: a new hypothesis Trends Neurosci 23 10 Suppl. 2000 S71 S77
37. J. Houeto, V. Mesnage, L. Mallet, B. Pillon, M. Gargiulo, and S.T. du Moncel Behavioural disorders, Parkinson's disease and sub-thalamic stimulation J Neurol Neurosurg Psychiatry 72 2002 701 707 (Pubitemid 34557009)
38. I.U. Isaias, C. Siri, R. Cilia, D. De Gaspari, G. Pezzoli, and A. Antonini The relationship between impulsivity and impulse control disorders in Parkinson's disease Mov Disord 23 3 2008 411 415
39. L. Ishihara, and C. Brayne What is the evidence for a premorbid parkinsonian personality: a systematic review Mov Disord 21 2006 1066 1072 (Pubitemid 44336588)
40. H. Jacobs, I. Heberlein, A. Vieregge, and P. Vieregge Personality traits in young patients with Parkinson's disease Acta Neurol Scand 103 2001 82 87 (Pubitemid 32113100)
41. K.J. Klos, J.H. Bower, K.A. Josephs, J.Y. Matsumoto, and J.E. Ahlskog Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy Parkinsonism Relat Disord 6 2005 381 386 (Pubitemid 41317806)
42. G.F. Koob, and M. Le Moal Drug abuse: hedonic homeostatic dysregulation Science 278 1997 52 58 (Pubitemid 27446270)
43. L.M. Koran, R.J. Faber, E. Aboujaoude, M.D. Large, and R.T. Serpe Estimated prevalence of compulsive buying behavior in the United States Am J Psychiatry 163 10 2006 1806 1812 (Pubitemid 44522491)
44. P. Krack, A. Batir, N. Van Blercom, S. Chabardes, V. Fraix, and C. Ardouin Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease N Engl J Med 349 20 2003 1925 1934 (Pubitemid 37409709)
45. R. Kurlan Disabling repetitive behaviors in Parkinson's disease Mov Disord 19 4 2004 433 437 (Pubitemid 38559646)
46. A.J. Larner Medical hazards of the Internet: gambling in Parkinson's disease Mov Disord 21 2006 1789 (Pubitemid 44742226)
47. A.D. Lawrence, A.H. Evans, and A.J. Lees Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry Lancet Neurol 2 2003 595 604 (Pubitemid 37162568)
48. A.J. Lawrence, A.D. Blackwell, R.A. Barker, F. Spagnolo, L. Clark, and M.R. Aitken Predictors of punding in Parkinson's disease: results from a questionnaire survey Mov Disord 16 2007 2339 2345 (Pubitemid 351155978)
49. S.Y. Lim, A.H. Evans, and J.M. Miyasaki Impulse control and related disorders in Parkinson's disease: review Ann N Y Acad Sci 1142 2008 85 107
50. S.Y. Lim, S.S. O'Sullivan, K. Kotschet, D.A. Gallagher, C. Lacey, and A.D. Lawrence Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease J Clin Neurosci 16 9 2009 1148 1152
51. C. Lu, A. Bharmal, and O. Suchowersky Gambling and Parkinson disease Arch Neurol 63 2 2006 298
52. A.G. Machado, G.K. Hiremath, F. Salazar, and A.R. Rezai Fracture of subthalamic nucleus deep brain stimulation hardware as a result of compulsive manipulation: case report Neurosurgery 57 6 2005 E131
53. E. Mamikonyan, A.D. Siderowf, J.E. Duda, M.N. Potenza, S. Horn, and M.B. Stern Long-term follow-up of impulse control disorders in Parkinson's disease Mov Disord 23 1 2008 75 80 (Pubitemid 351281221)
54. A. McKeon, K.A. Josephs, K.J. Klos, K. Hecksel, J.H. Bower, and J. Michael Bostwick Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy Parkinsonism Relat Disord 13 8 2007 516 519 (Pubitemid 350102309)
55. M. Menza, L. Golbe, R.A. Cody, and N. Forman Dopamine-related personality traits in Parkinson's disease Neurology 43 1993 505 508 (Pubitemid 23088482)
56. D. Merims, and N. Giladi Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease Parkinsonism Relat Disord 14 4 2008 273 280 (Pubitemid 351736001)
57. D. Merims, R. Galili-Mosberg, and E. Melamed Is there addiction to levodopa in patients with Parkinson's disease? Mov Disord 15 5 2000 1014 1016
58. F. Micheli, M. Fernandez Pardal, R. Giannaula, and S. Fahn What is it? Case 3, 1991: moaning in a man with parkinsonian signs Mov Disord 6 4 1991 376 378
59. H. Miwa, and T. Kondo Increased writing activity in Parkinson's disease: a punding-like behavior? Parkinsonism Relat Disord 11 5 2005 323 325 (Pubitemid 40982508)
60. J.M. Miyasaki, K. Al Hassan, A.E. Lang, and V. Voon Punding prevalence in Parkinson's disease Mov Disord 22 8 2007 1179 1181 (Pubitemid 47067232)
61. J.A. Molina, M.J. Sainz-Artiga, and A. Fraile Pathological gambling in Parkinson's disease: a behavioural manifestation of pharmacologic treatment Mov Disord 15 2000 869 872
62. P.A. Nausieda Sinemet abusers Clin Neuropharmacol 8 4 1985 318 327
63. M.J. Nirenberg, and C. Waters Compulsive eating and weight gain related to dopamine agonist use Mov Disord 21 2006 524 529
64. S.S. O'Sullivan, A.H. Evans, and A.J. Lees Punding in Parkinson's disease Pract Neurol 7 6 2007 397 399 (Pubitemid 350237716)
65. W.G. Ondo, and D. Lai Predictors of impulsivity and reward seeking behavior with dopamine agonists Parkinsonism Relat Disord 14 1 2008 28 32
66. F.R. Pezzella, C. Colosimo, N. Vanacore, S. Di Rezze, M. Chianese, and G. Fabbrini Prevalence and clinical features of hedonistic dysregulation syndrome in Parkinson's disease Mov Disord 20 2005 77 81 (Pubitemid 40277510)
67. G. Pontone, J.R. Williams, S.S. Bassett, and L. Marsh Clinical features associated with impulse control disorders in Parkinson disease Neurology 7 2006 1258 1261 (Pubitemid 44563839)
68. M.N. Potenza Should addictive disorders include non-substance-related conditions? Addiction 101 Suppl. 1 2006 142 151 (Pubitemid 44199506)
69. C.A. Rabinak, and M.J. Nirenberg Dopamine agonist withdrawal syndrome in Parkinson's disease Arch Neurol 67 1 2010 58 63
70. T.E. Robinson, and K.C. Berridge The psychology and neurobiology of addiction: an incentive-sensitization view Addiction 95 Suppl. 2 2000 S91 S117
71. M.C. Rodriguez-Oroz, J. Lopez-Azcarate, D. Garcia-Garcia, M. Alegre, J. Toledo, and M. Valencia Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease Brain 134 2011 36 49
72. L.M. Romito, M. Raja, A. Daniele, M.F. Contarino, A.R. Bentivoglio, and A. Barbier Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease Mov Disord 17 6 2002 1371 1374 (Pubitemid 36041360)
73. T. Rouaud, S. Lardeux, N. Panayotis, D. Paleressompoulle, M. Cador, and C. Baunez Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation Proc Natl Acad Sci U S A 107 3 2010 1196 1200
74. M. Sensi, R. Eleopra, M.A. Cavallo, E. Sette, P. Milani, and R. Quatrale Explosive-aggressive behavior related to bilateral subthalamic stimulation Parkinsonism Relat Disord 10 4 2004 247 251 (Pubitemid 38534619)
75. H.J. Shaffer, M.N. Hall, and J. Vander Bilt Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis Am J Public Health 89 9 1999 1369 1376 (Pubitemid 29404561)
76. L. Silveira-Moriyama, A.H. Evans, R. Katzenschlager, and A.J. Lees Punding and dyskinesias Mov Disord 21 2006 1214 1217
77. H.M. Smeding, A.E. Goudriaan, E.M. Foncke, P.R. Schuurman, J.D. Speelman, and B. Schmand Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease J Neurol Neurosurg Psychiatry 78 5 2007 517 519 (Pubitemid 46662902)
78. A.H. Spencer, H. Rickards, A. Fasano, and A.E. Cavanna The prevalence and clinical characteristics of punding in Parkinson's disease Mov Disord 26 2011 578 586
79. C. Téllez, M.L. Bustamante, P. Toro, and P. Venegas Addiction to apomorphine: a clinical case-centred discussion Addiction 101 11 2006 1662 1665 (Pubitemid 44527199)
80. S. Thobois, C. Ardouin, E. Lhommée, H. Klinger, C. Lagrange, and J. Xie Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation Brain 133 Pt 4 2010 1111 1127
81. A. Thomas, L. Bonanni, F. Gambi, I.A. Di, and M. Onofrj Pathological gambling in Parkinson's disease is reduced by amantadine Ann Neurol 68 3 2010 400 404
82. R.J. Uitti, C.M. Tanner, A.H. Rajput, C.G. Goetz, H.L. Klawans, and B. Thiessen Hypersexuality with antiparkinsonian therapy Clin Neuropharmacol 12 1989 375 383 (Pubitemid 20008761)
83. H.P. Vogel, and R. Schiffter Hypersexuality - a complication of dopaminergic therapy in Parkinson's disease Pharmacopsychiatria 16 1983 107 110 (Pubitemid 13002434)
84. N. Volkow, and T.K. Li The neuroscience of addiction Nat Neurosci 8 11 2005 1429 1430 (Pubitemid 41573649)
85. V. Voon Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease Mov Disord 19 4 2004 367 370 (Pubitemid 38559638)
86. V. Voon, and S. Fox Medication-related impulse control and repetitive behaviours in Parkinson disease Arch Neurol 64 2 2007 1089 1096 (Pubitemid 47258066)
87. V. Voon, K. Hassan, M. Zurowski, M. de Souza, T. Thomsen, and S. Fox Prevalence of repetitive and reward-seeking behaviors in Parkinson disease Neurology 67 2006 1254 1257 (Pubitemid 44563838)
88. V. Voon, K. Hassan, M. Zurowski, S. Duff-Canning, M. de Souza, and S. Fox Prospective prevalence of pathological gambling and medication association in Parkinson's disease Neurology 66 2006 1750 1752 (Pubitemid 43964638)
89. V. Voon, P.O. Fernagut, J. Wickens, C. Baunez, M. Rodriguez, and N. Pavon Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders Lancet Neurol 8 2009 1140 1149
90. V. Voon, M. Sohr, A.E. Lang, M. Potenza, A.D. Siderowf, and J. Whetteckey Impulse control disorders in Parkinson disease: a multicenter case-control study Ann Neurol 69 2011 986 996
91. D. Weintraub, A.D. Siderowf, M.N. Potenza, J. Goveas, K.H. Morales, and J.E. Duda Association of dopamine agonist use with impulse control disorders in Parkinson disease Arch Neurol 7 2006 969 973 (Pubitemid 44036299)
92. D. Weintraub, S. Stewart, J. Shea, K.E. Lyons, R. Pahwa, and E.D. Driver-Dunckley Validation of the Questionnaire for Impulsive-compulsive disorders in Parkinson's disease Mov Disord 24 10 2009 1461 1467
93. D. Weintraub, J. Koester, M.N. Potenza, A.D. Siderowf, M. Stacy, and V. Voon Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients Arch Neurol 67 5 2010 589 595
94. T. Witjas, E. Kaphan, J.P. Azulay, O. Blin, M. Ceccaldi, and J. Pouget Nonmotor fluctuations in Parkinson's disease: frequent and disabling Neurology 59 3 2002 408 413 (Pubitemid 34857934)
95. T. Witjas, C. Baunez, J.M. Henry, M. Delfini, J. Regis, and A.A. Cherif Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation Mov Disord 20 8 2005 1052 1055 (Pubitemid 41419526)
96. T. Witjas, E. Kaphan, J. Régis, E. Jouve, A.A. Chérif, and J.C. Péragut Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease Mov Disord 22 12 2007 1729 1734 (Pubitemid 47610462)